Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

67 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy.
O'Connor AE, Gallagher WM, Byrne AT. O'Connor AE, et al. Among authors: byrne at. Photochem Photobiol. 2009 Sep-Oct;85(5):1053-74. doi: 10.1111/j.1751-1097.2009.00585.x. Epub 2009 Aug 3. Photochem Photobiol. 2009. PMID: 19682322 Review.
Mechanism of cell death mediated by a BF2-chelated tetraaryl-azadipyrromethene photodynamic therapeutic: dissection of the apoptotic pathway in vitro and in vivo.
O'Connor AE, Mc Gee MM, Likar Y, Ponomarev V, Callanan JJ, O'shea DF, Byrne AT, Gallagher WM. O'Connor AE, et al. Among authors: byrne at. Int J Cancer. 2012 Feb 1;130(3):705-15. doi: 10.1002/ijc.26073. Epub 2011 May 26. Int J Cancer. 2012. PMID: 21413012 Free PMC article.
Bioluminescent imaging: a critical tool in pre-clinical oncology research.
O'Neill K, Lyons SK, Gallagher WM, Curran KM, Byrne AT. O'Neill K, et al. Among authors: byrne at. J Pathol. 2010 Feb;220(3):317-27. doi: 10.1002/path.2656. J Pathol. 2010. PMID: 19967724 Review.
Supramolecular photonic therapeutic agents.
McDonnell SO, Hall MJ, Allen LT, Byrne A, Gallagher WM, O'Shea DF. McDonnell SO, et al. J Am Chem Soc. 2005 Nov 30;127(47):16360-1. doi: 10.1021/ja0553497. J Am Chem Soc. 2005. PMID: 16305199
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy.
Smeets D, Miller IS, O'Connor DP, Das S, Moran B, Boeckx B, Gaiser T, Betge J, Barat A, Klinger R, van Grieken NCT, Cremolini C, Prenen H, Mazzone M, Depreeuw J, Bacon O, Fender B, Brady J, Hennessy BT, McNamara DA, Kay E, Verheul HM, Maarten N, Gallagher WM, Murphy V, Prehn JHM, Koopman M, Punt CJA, Loupakis F, Ebert MPA, Ylstra B, Lambrechts D, Byrne AT. Smeets D, et al. Among authors: byrne at. Nat Commun. 2018 Oct 5;9(1):4112. doi: 10.1038/s41467-018-06567-6. Nat Commun. 2018. PMID: 30291241 Free PMC article.
Synergistic interaction between trastuzumab and EGFR/HER-2 tyrosine kinase inhibitors in HER-2 positive breast cancer cells.
O'Donovan N, Byrne AT, O'Connor AE, McGee S, Gallagher WM, Crown J. O'Donovan N, et al. Among authors: byrne at. Invest New Drugs. 2011 Oct;29(5):752-9. doi: 10.1007/s10637-010-9415-5. Epub 2010 Mar 16. Invest New Drugs. 2011. PMID: 20229355
Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary.
Jarzabek MA, Sweeney KJ, Evans RL, Jacobs AH, Stupp R, O'Brien D, Berger MS, Prehn JH, Byrne AT. Jarzabek MA, et al. Among authors: byrne at. Drug Discov Today. 2013 Nov;18(21-22):1052-66. doi: 10.1016/j.drudis.2013.06.004. Epub 2013 Jun 20. Drug Discov Today. 2013. PMID: 23792334 Review.
Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors.
Rani S, Corcoran C, Shiels L, Germano S, Breslin S, Madden S, McDermott MS, Browne BC, O'Donovan N, Crown J, Gogarty M, Byrne AT, O'Driscoll L. Rani S, et al. Among authors: byrne at. Cancer Res. 2014 Jul 15;74(14):3821-33. doi: 10.1158/0008-5472.CAN-13-2053. Epub 2014 May 29. Cancer Res. 2014. PMID: 24876102
The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?
Joerger M, Finn SP, Cuffe S, Byrne AT, Gray SG. Joerger M, et al. Among authors: byrne at. Expert Opin Ther Targets. 2016 Nov;20(11):1339-1356. doi: 10.1080/14728222.2016.1206891. Epub 2016 Jul 11. Expert Opin Ther Targets. 2016. PMID: 27353429 Review.
Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer.
Zuurbier L, Rahman A, Cordes M, Scheick J, Wong TJ, Rustenburg F, Joseph JC, Dynoodt P, Casey R, Drillenburg P, Gerhards M, Barat A, Klinger R, Fender B, O'Connor DP, Betge J, Ebert MP, Gaiser T, Prehn JHM, Griffioen AW, van Grieken NCT, Ylstra B, Byrne AT, van der Flier LG, Gallagher WM, Postel R. Zuurbier L, et al. Among authors: byrne at. Oncotarget. 2017 Jun 27;8(26):42949-42961. doi: 10.18632/oncotarget.17306. Oncotarget. 2017. PMID: 28487489 Free PMC article.
67 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback